Category: Lynch Syndrome
Can an Aspirin a Day Prevent Colorectal Cancer in People with Lynch Syndrome?
![a hand holding a pill with several other pills on the table and a pill bottle and a body with an exposed colon](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2019/10/2019-10_blog_aspirin.jpg)
Encouraging news for group at much greater risk of CRC Lynch syndrome (LS) is the most common cause of hereditary colorectal (colon) cancer (CRC). People with LS have a 50-70% risk of developing CRC in their lifetimes – far higher than the 4% risk within the general population where CRC is a leading cause of Read More >
Posted on byUniversal Screening for Lynch Syndrome: Can Tumor Sequencing Have a Larger Public Health Impact on Treatment and Prevention of Colorectal Cancer?
![Universal Screening with an arrow labeled Lynch Syndrome and DNA below it](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2018/05/2018-05_blog_lynch.jpg)
Lynch syndrome (LS) is the most common hereditary syndrome associated with increased risk of colorectal cancer (CRC), accounting for about 3% of CRC patients. LS is a dominantly inherited condition with mutations in several mismatch repair (MMR) genes. Persons with LS are also at increased risk for endometrial and other cancers. Lynch syndrome affects 1 Read More >
Posted on byRecommendations and Reality: What Personal Stories of Hereditary Cancer Can Tell Us
![four photos of Sarah, Dave, Zac and Gloria (reading order starting top left)](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2015/10/flickr_blog.jpg)
In public health and clinical medicine, recommendations for interventions are generally based on the evidence supporting improved health outcomes. Studies that inform these recommendations often focus on the evidence for benefits, especially when those benefits include lives saved. The harms that affect quality of life are more challenging to quantify and sometimes go unmeasured. Recommendations Read More >
Posted on by 1 CommentA Public Health Genomic State-by-State Clickable Map: Accelerating Implementation of Genomics Applications to Improve Population Health
![US Map](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2013/06/usmap1-160x80.jpg)
In recent years, public health programs in several states have used innovative approaches to implement evidence-based genomic testing recommendations in an effort to improve health outcomes for people at increased hereditary risk for breast, ovarian, colorectal and other cancers. For example, the Michigan Department of Community Health [PDF 1.04 MB] has partnered with payers in Read More >
Posted on by 1 CommentMaking Universal Screening for Lynch Syndrome a Reality: The Lynch Syndrome Screening Network
![flow chart individual](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2012/03/FlowChartIndividual.jpg)
Every day, about 400 people in the United States are diagnosed with colorectal cancer. Approximately twelve of them have Lynch syndrome, a hereditary condition that increases the risk of colorectal cancer and other cancers. Identifying people with Lynch syndrome could have substantial health benefits for them, their families, and communities. Read More >
Posted on by 1 Comment